NCT00146835View on ClinicalTrials.gov

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

CompletedOBSERVATIONAL
Enrollment

120,794

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Hepatitis BPoliomyelitisDiphtheriaTetanusAcellular Pertussis
Interventions
BIOLOGICAL

Pediarix

1 or more injections

BIOLOGICAL

Licensed DTPa containing vaccine

1 or more injections

BIOLOGICAL

Prevnar®: (Wyeth)

Concomitant vaccination

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

GlaxoSmithKline

INDUSTRY